Some popular antidepressants in early pregnancy could double the risk of an unborn child developing a heart defect, an expert has warned.
Professor Stephen Pilling of the National Institute for Health and Care Excellence (NICE), said that evidence suggests that there is a risk associated with the Selective serotonin reuptake inhibitor (SSRI), the BBC reported.
He said that a lot of effort is put in to dissuade women from smoking or drinking alcohol during pregnancy, however, its not the same with antidepressant medication, which may be carrying similar - if not greater - risks.
Pilling said that the guidance is now going be re-written to take in to account evidence that the SSRI antidepressants, as a group, are associated to heart defects in babies.
He asserted that the risk of a child being born with a heart defect is around two in 100; but the new evidence shows that if the mother took an SSRI during early pregnancy the risk raises to around four in 100.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
